Novartis SG&A Expense (TTM) Analysis | YCharts

Novartis AG (NVS)

159.99 -3.10 (-1.90%) USD | NYSE | Sep 04, 16:00

152.44 -7.55 (-4.72%) After-Hours: 20:00

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for NVS.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View SG&A Expense (TTM) Chart

Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2001. Start Trial.

Date	Value
June 30, 2026	13.14B
March 31, 2026	13.39B
December 31, 2025	13.30B
September 30, 2025	13.33B
June 30, 2025	13.20B
March 31, 2025	12.80B
December 31, 2024	12.58B
September 30, 2024	12.54B
June 30, 2024	12.47B
March 31, 2024	12.47B
December 31, 2023	12.52B
September 30, 2023	12.26B
June 30, 2023	12.10B
March 31, 2023	12.59B
December 31, 2022	13.21B
September 30, 2022	14.01B
June 30, 2022	14.70B
March 31, 2022	14.87B
December 31, 2021	14.89B
September 30, 2021	14.82B
June 30, 2021	14.63B
March 31, 2021	14.24B
December 31, 2020	14.20B
September 30, 2020	14.18B
June 30, 2020	14.31B

Date	Value
March 31, 2020	14.52B
December 31, 2019	14.37B
September 30, 2019	14.14B
June 30, 2019	13.85B
March 31, 2019	13.76B
December 31, 2018	13.72B
September 30, 2018	14.08B
June 30, 2018	14.50B
March 31, 2018	14.81B
December 31, 2017	15.00B
September 30, 2017	14.79B
June 30, 2017	14.52B
March 31, 2017	14.36B
December 31, 2016	14.19B
September 30, 2016	14.24B
June 30, 2016	14.30B
March 31, 2016	14.27B
December 31, 2015	14.25B
September 30, 2015	14.33B
June 30, 2015	14.43B
March 31, 2015	14.71B
December 31, 2014	15.76B
September 30, 2014	15.94B
June 30, 2014	16.05B
March 31, 2014	15.93B

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years

Start Trial

--

Minimum

--

Maximum

--

Average

--

Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks

Start Trial

Roche Holding AG	29.37B
AstraZeneca PLC	585.31M
GSK Plc	12.34B
Johnson & Johnson	25.14B
Eli Lilly & Co.	12.24B